Federica C.
- Country
- Italy
- Department
- Department of Biotecnologie Molecolari e Scienze per la Salute
Research Overview
- Phase I-II Study of Romidepsin Combined with CHOEP for Initial Treatment in Young Patients with Nodal Peripheral T-Cell Lymphomas Prior to Hematopoietic Stem Cell Transplantation
- A Phase I First-in-Human Study to Evaluate the Safety and Pharmacokinetics of KK2223 in Patients with T-cell Non-Hodgkin Lymphoma
- Phase 3 Randomized Study of Tirabrutinib Versus Rituximab-Temozolomide in Relapsed/Refractory Primary Central Nervous System Lymphoma
Data & Insights
Has run more than one trial at 183 of 378 partner sites.
Specializations
B-Cell Lymphoma Studies
Focused on investigating treatments for Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma, particularly in elderly populations. Explores innovative therapeutic combinations including immunochemotherapy and targeted treatments.
- Elderly DLBCL Treatment Protocols
- Novel Drug Combinations
- First-line Therapies
T-Cell Lymphoma Research
Specializes in the treatment of Peripheral T-Cell Lymphomas and related conditions. Studies novel therapeutic approaches including combination treatments with stem cell transplantation and innovative drug regimens.
- Nodal Peripheral T-Cell Lymphomas
- Combination Therapy Approaches
- Treatment Response Assessment
Specialized Lymphoma Types
Investigates treatments for rare lymphoma variants including Ocular Adnexal Marginal Zone Lymphoma, Mantle Cell Lymphoma, and MALT Lymphoma. Explores targeted therapeutic approaches and maintenance strategies.
- Rare Lymphoma Variants
- Targeted Therapies
- Maintenance Treatment Protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.